Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 10Tumor-Agnostic 7Gynecologic 4Genitourinary 4Gastrointestinal 3Sarcoma 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1Classical hematology 1

Conditions

Sarcoma 9Osteosarcoma 4Sarcoma, Ewing 3Rhabdomyosarcoma 3Neuroblastoma 3Neoplasms 3Medulloblastoma 3Glioma 3Ependymoma 3Central Nervous System Neoplasms 3Carcinosarcoma 3Wilms Tumor 2Rhabdoid Tumor 2Recurrence 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasm Metastasis 2Lymphoma, Non-Hodgkin 2Histiocytosis, Langerhans-Cell 2Hepatoblastoma 2Glioblastoma 2Endometrial Neoplasms 2Carcinoma, Endometrioid 2Breast Neoplasms 2Xanthogranuloma, Juvenile 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Sarcoma, Synovial 1Prostatic Neoplasms 1Pheochromocytoma 1Pathologic Complete Response 1

Interventions

pembrolizumab 11Gemcitabine 10Doxorubicin 10Cyclophosphamide 9Specimen Handling 8Nivolumab 8Ibandronic Acid 8pazopanib 7Radiosurgery 6Magnetic Resonance Spectroscopy 6Imatinib Mesylate 6Biopsy 6Bevacizumab 6Irinotecan 5regorafenib 4Zoledronic Acid 4Ipilimumab 4Ifosfamide 4Fluorouracil 4Docetaxel 4Cetuximab 4sargramostim 3conatumumab 3cemiplimab 3Sunitinib 3Radiation 3Paclitaxel 3Leucovorin 3Cryosurgery 3Cisplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasm Metastasis × olaparib × Sarcoma × Clear all
NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed
603 enrolled
Sarcoma

Neoplasm Metastasis, Sarcoma

NCT01583543 2017-05-19

Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma

Massachusetts General Hospital

Phase 2 Completed
12 enrolled 7 charts
Sarcoma

Neoplasm Metastasis, Recurrence, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡